Biostax Corp.
BTAX · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $6 | $22 | $1 | $7 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $3 | $3 |
| Enterprise Value | $7 | $22 | $4 | $10 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$3 | $4 | $2 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$4 | $4 | $2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.03 | -0.1 | 0.38 | 0.11 |
| % Growth | 70% | -126.3% | 245.5% | – |
| Operating Cash Flow | -$0 | -$1 | – | -$0 |
| Capital Expenditures | $0 | -$1 | – | $0 |
| Free Cash Flow | -$0 | -$1 | – | -$0 |